CIK 0001690585 · Non-accelerated filer<br>Smaller reporting company
Dianthus Therapeutics, Inc. /DE/
Sign in to watch- Ticker
- DNTH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 929-999-4055
- Business address
- 7 TIMES SQUARE, 43RD FLOOR, NEW YORK, NY, 10036
- Former names
- Magenta Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $16,043,610
- in 4 filings, $16.0M under 10b5-1 plans
Net −$16,043,610. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-01 | Fairmount Funds Management LLC Director | Other disposition | −58,857 | 0 | ||
| 2024-04-01 | Fairmount Funds Management LLC Director | Other acquisition | +58,857 | 2,700,691 | ||
| 2024-01-24 | CARR EDWARD CHIEF ACCOUNTING OFFICER | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2024-01-24 | Veness Adam M SVP, General Counsel and Sec. | Grant or award · Stock Option (Right to Buy) | +110,000 | 110,000 | ||
| 2024-01-24 | Randhawa Simrat CHIEF MEDICAL OFFICER | Grant or award · Stock Option (Right to Buy) | +120,000 | 120,000 | ||
| 2024-01-24 | Savitz Ryan CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (Right to Buy) | +120,000 | 120,000 | ||
| 2024-01-24 | Garcia Marino CEO AND PRESIDENT | Grant or award · Stock Option (Right to Buy) | +275,000 | 275,000 | ||
| 2024-01-22 | MOULDER LEON O JR Director | Grant or award | +166,667 | $12.00 | $2.0M | 1,436,745 |
| 2024-01-22 | Fairmount Funds Management LLC Director | Grant or award | +834,334 | $12.00 | $10.0M | 2,762,837 |
| 2024-01-22 | Fairmount Funds Management LLC Director | Grant or award · Pre-Funded Warrants (Right to Buy) | +832,333 | $12.00 | $10.0M | 832,333 |
| 2024-01-22 | Meng Lei Director | Grant or award | +1,500,000 | $12.00 | $18.0M | 2,717,554 |
| 2024-01-22 | Meng Lei Director | Grant or award · Pre-Funded Warrants (Right to Buy) | +1,833,333 | $12.00 | $22.0M | 1,833,333 |
| 2023-09-29 | Fairmount Funds Management LLC Director | Purchase | +24,670 | $13.63 | $336K | 1,928,503 |
| 2023-09-26 | Fairmount Funds Management LLC Director | Purchase | +30,000 | $13.15 | $395K | 1,903,833 |
| 2023-09-22 | Randhawa Simrat Chief Medical Officer | Purchase | +2,000 | $13.20 | $26K | 4,000 |
| 2023-09-21 | Randhawa Simrat Chief Medical Officer | Purchase | +2,000 | $13.20 | $26K | 2,000 |
| 2023-09-19 | Fairmount Funds Management LLC Director | Purchase | +30,000 | $13.20 | $396K | 1,873,833 |
| 2023-09-13 | Fairmount Funds Management LLC Director | Purchase | +9,367 | $11.76 | $110K | 1,843,833 |
| 2023-09-12 | Fairmount Funds Management LLC Director | Purchase | +14,887 | $10.85 | $162K | 1,834,466 |
| 2023-09-11 | Meng Lei Director | Grant or award · Stock Option (Right to Buy) | +6,500 | 6,500 |
Page 12 of 24 · 470 trades